Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX – Get Rating) SVP Tejal Vakharia sold 8,642 shares of the stock in a transaction dated Monday, December 12th. The stock was sold at an average price of $18.42, for a total transaction of $159,185.64. Following the transaction, the senior vice president now directly owns 222,604 shares in the company, valued at approximately $4,100,365.68. The transaction was disclosed in a filing with the SEC, which is available through this link.
Allscripts Healthcare Solutions Stock Performance
MDRX stock traded down $0.22 during midday trading on Monday, reaching $18.32. 1,564,766 shares of the company’s stock traded hands, compared to its average volume of 1,571,993. The stock has a market cap of $2.00 billion, a P/E ratio of 42.58, a PEG ratio of 1.75 and a beta of 1.01. Allscripts Healthcare Solutions, Inc. has a 52-week low of $13.59 and a 52-week high of $23.25. The stock’s 50-day moving average is $16.44 and its 200 day moving average is $16.25. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.17.
Allscripts Healthcare Solutions (NASDAQ:MDRX – Get Rating) last posted its earnings results on Thursday, November 3rd. The software maker reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.15 by $0.05. The company had revenue of $151.90 million during the quarter, compared to analysts’ expectations of $152.79 million. Allscripts Healthcare Solutions had a net margin of 7.25% and a return on equity of 10.74%. Allscripts Healthcare Solutions’s quarterly revenue was up 5.0% on a year-over-year basis. During the same period last year, the company posted $0.21 earnings per share. As a group, analysts anticipate that Allscripts Healthcare Solutions, Inc. will post 0.65 EPS for the current year.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the company. CWM LLC grew its position in shares of Allscripts Healthcare Solutions by 578.4% in the 3rd quarter. CWM LLC now owns 2,103 shares of the software maker’s stock worth $32,000 after buying an additional 1,793 shares during the last quarter. C M Bidwell & Associates Ltd. purchased a new stake in Allscripts Healthcare Solutions during the 3rd quarter worth approximately $33,000. Robeco Institutional Asset Management B.V. purchased a new stake in shares of Allscripts Healthcare Solutions in the 3rd quarter valued at $93,000. MQS Management LLC purchased a new stake in shares of Allscripts Healthcare Solutions in the 2nd quarter valued at $154,000. Finally, Prelude Capital Management LLC purchased a new stake in shares of Allscripts Healthcare Solutions in the 2nd quarter valued at $156,000. Hedge funds and other institutional investors own 99.76% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on MDRX shares. StockNews.com started coverage on shares of Allscripts Healthcare Solutions in a report on Wednesday, October 12th. They issued a “hold” rating on the stock. Piper Sandler reiterated an “overweight” rating and issued a $17.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Friday, November 4th. TheStreet upgraded shares of Allscripts Healthcare Solutions from a “c+” rating to a “b-” rating in a research note on Wednesday, November 30th. Argus raised shares of Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating and set a $26.00 target price for the company in a research report on Wednesday, December 7th. They noted that the move was a valuation call. Finally, The Goldman Sachs Group raised shares of Allscripts Healthcare Solutions from a “neutral” rating to a “buy” rating and increased their target price for the company from $22.00 to $23.00 in a research report on Tuesday, November 8th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the company. According to data from MarketBeat, Allscripts Healthcare Solutions currently has a consensus rating of “Moderate Buy” and an average target price of $22.67.
About Allscripts Healthcare Solutions
Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Allscripts Healthcare Solutions, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Allscripts Healthcare Solutions wasn’t on the list.
While Allscripts Healthcare Solutions currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here